IceCure Medical Ltd (ICCM) Regains Nasdaq Compliance

Go back to IceCure Medical Ltd (ICCM) Regains Nasdaq Compliance

IceCure Medical Regains Full Nasdaq Compliance with Nasdaq Minimum Closing Bid Price Rule

January 6, 2025 8:30 AM EST

CAESAREA, Israel, Jan. 6, 2025 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today... More